wockhardt | home agm.pdf · validated by the recent international ims report. the prognosis 2007...

10

Upload: others

Post on 09-Aug-2020

4 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Wockhardt | Home AGM.pdf · validated by the recent international IMS Report. The Prognosis 2007 study shows the pharma emerging markets in Europe to be France, Germany and 11K. Thankfully,
Page 2: Wockhardt | Home AGM.pdf · validated by the recent international IMS Report. The Prognosis 2007 study shows the pharma emerging markets in Europe to be France, Germany and 11K. Thankfully,
Page 3: Wockhardt | Home AGM.pdf · validated by the recent international IMS Report. The Prognosis 2007 study shows the pharma emerging markets in Europe to be France, Germany and 11K. Thankfully,
Page 4: Wockhardt | Home AGM.pdf · validated by the recent international IMS Report. The Prognosis 2007 study shows the pharma emerging markets in Europe to be France, Germany and 11K. Thankfully,
Page 5: Wockhardt | Home AGM.pdf · validated by the recent international IMS Report. The Prognosis 2007 study shows the pharma emerging markets in Europe to be France, Germany and 11K. Thankfully,
Page 6: Wockhardt | Home AGM.pdf · validated by the recent international IMS Report. The Prognosis 2007 study shows the pharma emerging markets in Europe to be France, Germany and 11K. Thankfully,
Page 7: Wockhardt | Home AGM.pdf · validated by the recent international IMS Report. The Prognosis 2007 study shows the pharma emerging markets in Europe to be France, Germany and 11K. Thankfully,
Page 8: Wockhardt | Home AGM.pdf · validated by the recent international IMS Report. The Prognosis 2007 study shows the pharma emerging markets in Europe to be France, Germany and 11K. Thankfully,
Page 9: Wockhardt | Home AGM.pdf · validated by the recent international IMS Report. The Prognosis 2007 study shows the pharma emerging markets in Europe to be France, Germany and 11K. Thankfully,
Page 10: Wockhardt | Home AGM.pdf · validated by the recent international IMS Report. The Prognosis 2007 study shows the pharma emerging markets in Europe to be France, Germany and 11K. Thankfully,